369 related articles for article (PubMed ID: 10089705)
1. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
[TBL] [Abstract][Full Text] [Related]
2. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
[TBL] [Abstract][Full Text] [Related]
3. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.
Muratori P; Muratori L; Ferrari R; Cassani F; Bianchi G; Lenzi M; Rodrigo L; Linares A; Fuentes D; Bianchi FB
Am J Gastroenterol; 2003 Feb; 98(2):431-7. PubMed ID: 12591064
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
5. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
[TBL] [Abstract][Full Text] [Related]
6. [Atypical primary biliary cirrhosis or autoimmune cholangitis?].
Primo J; Miralles A; Ferrando J; Albert A; Julve R; Gómez A; García L
Gastroenterol Hepatol; 1999 Dec; 22(10):505-9. PubMed ID: 10650665
[TBL] [Abstract][Full Text] [Related]
7. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
[TBL] [Abstract][Full Text] [Related]
9. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
10. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
Nakamura M; Shimizu-Yoshida Y; Takii Y; Komori A; Yokoyama T; Ueki T; Daikoku M; Yano K; Matsumoto T; Migita K; Yatsuhashi H; Ito M; Masaki N; Adachi H; Watanabe Y; Nakamura Y; Saoshiro T; Sodeyama T; Koga M; Shimoda S; Ishibashi H
J Hepatol; 2005 Mar; 42(3):386-92. PubMed ID: 15710222
[TBL] [Abstract][Full Text] [Related]
11. [Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?].
Saló J; Caballería L; Bruguera M; Parés A; Rodés J
Gastroenterol Hepatol; 1997 Jan; 20(1):5-10. PubMed ID: 9072202
[TBL] [Abstract][Full Text] [Related]
12. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.
Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
Hum Antibodies Hybridomas; 1996; 7(4):167-74. PubMed ID: 9140728
[TBL] [Abstract][Full Text] [Related]
13. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis.
Bandin O; Courvalin JC; Poupon R; Dubel L; Homberg JC; Johanet C
Hepatology; 1996 May; 23(5):1020-4. PubMed ID: 8621127
[TBL] [Abstract][Full Text] [Related]
14. Serum immunological profile in patients with chronic autoimmune cholestasis.
Romero-Gómez M; Wichmann I; Crespo J; Parés A; Rodrigo L; Alvarez A; Diago M; Pons-Romero F; Sanchez-Munoz D; Aguilar-Reina J; Andrade RJ; Salmeron J; Sánchez-Pobre P; Rebollo JM; Martin-Vivaldi R; Castellano-Megias V; Nuñez-Roldan A; Bruguera M;
Am J Gastroenterol; 2004 Nov; 99(11):2150-7. PubMed ID: 15554996
[TBL] [Abstract][Full Text] [Related]
15. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis.
Taylor SL; Dean PJ; Riely CA
Am J Surg Pathol; 1994 Jan; 18(1):91-9. PubMed ID: 8279631
[TBL] [Abstract][Full Text] [Related]
16. Is prevalence of PBC underestimated in patients with systemic sclerosis?
Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
[TBL] [Abstract][Full Text] [Related]
17. Nuclear envelope protein autoantibodies in primary biliary cirrhosis.
Courvalin JC; Worman HJ
Semin Liver Dis; 1997 Feb; 17(1):79-90. PubMed ID: 9089913
[TBL] [Abstract][Full Text] [Related]
18. Does the diagnosis of primary biliary cirrhosis or autoimmune cholangitis depend on the 'phase' of the disease?
Kadokawa Y; Omagari K; Ohba K; Masuda J; Hazama H; Kinoshita H; Ohnita K; Mizuta Y; Tanioka H; Imanishi T; Kohno S
Liver Int; 2005 Apr; 25(2):317-24. PubMed ID: 15780056
[TBL] [Abstract][Full Text] [Related]
19. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.
Mattalia A; Lüttig B; Rosina F; Leung PS; Van de Water J; Bauducci M; Ciancio A; Böker KH; Worman H; Cooper RL; Manns M; Ansari A; Rizzetto M; Gershwin ME
J Autoimmun; 1997 Oct; 10(5):491-7. PubMed ID: 9376077
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
